News Related to Mesenchymal Stem Cell Therapy

Related coverage linked through entity extraction aliases.

FDA Announces Reforms to Cell and Gene Therapy Manufacturing Requirements

Mar 12, 2026

The FDA issued reforms on January 11, 2026, loosening chemistry, manufacturing, and control requirements for cell and gene therapy products to advance innovation and accommodate the unique complexity of these treatments.

Stem Cell Therapy Market to Reach $59.70 Billion by 2035

Feb 25, 2026

The global stem cell therapy market is projected to grow from $18.13 billion in 2025 to $59.70 billion by 2035 at a 12.66% CAGR, driven by chronic disease prevalence and regenerative medicine advances.